Home » Featured » Page 29
Featured
In an effort to meet global supply demands, Sanofi has agreed to support the manufacturing of a COVID-19 vaccine made by Janssen Pharmaceutical NV and Janssen Pharmaceuticals, Inc., both of which are part of Johnson & Johnson.
The Janssen candidate has been submitted to the U.S. Food and Drug... Read More »
Five COVID-19 vaccine manufacturers assured Congress Tuesday that they are closely watching the emergence of new variants of COVID-19 and are optimistic the two vaccines currently approved in the United States and a third poised for approval will treat those new variants that have emerged in the... Read More »
U.S. Sens. Jon Tester (D-MT) and Jerry Moran (R-KS) are urging President Joe Biden to add the Secretary of the Department of Veterans Affairs (VA) to the Defense Production Act Committee (DPAC).
The DPAC advises the President on the most effective use of the Defense Production Act (DPA) to... Read More »
A public health emergency was declared in Texas this week by the U.S. Department of Health and Human Services (HHS) Acting Secretary Norris Cochran due to recent winter storms that left millions without power.
President Joe Biden had already declared an emergency in the state last week.... Read More »
With money appropriated by Congress last year, President Joe Biden pledged a total of $4 billion to the global COVAX initiative to get poorer nations access to COVID-19 vaccines.
The announcement, made during a virtual G7 Summit, also encouraged partners within that group of wealthy nations to... Read More »
Federal agents with Homeland Security Investigations (HSI) have seized approximately 11 million counterfeit 3M N95 respirator masks in recent weeks.
The effort resulted from a collaboration between the U.S. Department of Homeland Security (DHS) and manufacturer 3M.
“These seizures... Read More »
Following the World Health Organization (WHO) emergency use listing of the AstraZeneca/University of Oxford COVID-19 vaccine this week, the COVAX initiative announced it intends the bulk of the first deliveries to occur in March.
COVAX is finalizing the first and second quarter allocations of... Read More »
Leading health and public health organizations in the United States are seeking $4.5 billion in additional annual funding for states, localities, tribes, and territories to support public health infrastructure and workforce.
Representatives from 316 organizations sent a letter to Congressional... Read More »
Republican members of the House Committee on Homeland Security are urging Biden administration officials not to roll back border security or immigration enforcement policies.
In a letter to President Biden, the committee members warn of a surge in encounters at the border at a time when U.S.... Read More »
The United States Departments of Health and Human Services (HHS) and Defense (DoD) will purchase another 100 million doses each of the COVID-19 vaccines offered by Pfizer Inc. and Moderna Inc. by the end of July.
President Joe Biden announced the deals last week, in a speech delivered at the... Read More »
New legislation from U.S. Sens. Mike Rounds (R-SD) and Tammy Duckworth (D-IL) attempts to guarantee maximized use of the Defense Production Act (DPA) during emergency response and to increase domestic production of critical medical supplies.
The Public Health Emergency (PHE) Production Act,... Read More »
A collection of four United States representatives reintroduced the Saracini Enhanced Aviation Safety Act this week in a bipartisan effort to require the installation of secondary cockpit barriers on passenger aircraft to prevent future events like those witnessed on Sept. 11, 2001.
The bill is... Read More »
Frustrated by ongoing cyber threats from the United States and abroad, members of the U.S. House Homeland Security Committee said Wednesday they are developing new legislation that would expand the powers of the Cybersecurity and Infrastructure Security Agency, currently an operational component... Read More »
Following preliminary data that showed the AstraZeneca/Oxford COVID-19 vaccine to have minimal effect in preventing mild to moderate cases of a South African variant, the global COVAX initiative has nevertheless stressed the need to assess its efficacy against more severe illness.
Preliminary... Read More »
Emergent BioSolutions Inc. on Monday hosted Maryland Gov. Larry Hogan at the multinational biopharmaceutical company’s East Baltimore, Md., Bayview facility where the Johnson & Johnson COVID-19 vaccine candidate is being manufactured.
Emergent’s Bayview facility, which is designated by... Read More »
The Federal Emergency Management Agency (FEMA) has set aside approximately $1.98 billion to states, tribes, territories as well as Washington D.C., for community vaccination centers.
Currently, there are 175 federally supported vaccine centers operational across the country. The federal... Read More »
New legislation introduced in both chambers of Congress last week -- the Community Immunity During COVID-19 Act -- proposes support for vaccination efforts and to reverse drops in vaccination rates through a mix of funding for local initiatives and access to primary care services.
The effort is... Read More »
Following efficacy and safety data reports released earlier, Johnson & Johnson announced today that Janssen Biotech, Inc. -- J&J’s pharmaceutical arm -- has applied for Emergency Use Authorization from the United States Food and Drug Administration (FDA) for its COVID-19 vaccine candidate.... Read More »
The results of Phase 3 clinical trials of COVID-19 Vaccine AstraZeneca in the United Kingdom, Brazil, and South Africa were released this week in The Lancet, proving the vaccine to be safe and effective, including preventing any severe cases for at least 22 days after the first dose.
All told,... Read More »
U.S. Sen. Elizabeth Warren (D-MA) and Rep. Jan Schakowsky (D-IL) introduced legislation to publicly manufacture personal protective equipment, prescription drugs, and other medical supplies necessary to fight the COVID-19 pandemic.
The Pandemic Emergency Manufacturing Act of 2021 authorizes the... Read More »
Members of the Democrat-controlled U.S. House Energy and Commerce Committee argued Wednesday the Trump administration’s actions on COVID-19 were inadequate to bring the pandemic under control and only the massive expenditure being called for by President Joe Biden will be enough to defeat the... Read More »
The United States Departments of Defense (DoD) and Health and Human Services (HHS) awarded $231.8 million to Ellume USA LLC this week to expand the domestic production capacity of its COVID-19 Home Test.
These funds will increase Ellume’s U.S. production capacity by 640,000 tests per day by... Read More »
A new forecast from the Institute for Health Metrics and Evaluation at the University of Washington establishes the danger of two new variants of COVID-19, warning of the possibility of a surge of deaths later this year, even despite the vaccine rollout.
According to the report, B.1.351 -- the... Read More »
Novavax, Inc. demonstrated a strong showing of its COVID-19 vaccine last week, posting an 89.3 percent efficacy in a United Kingdom-based phase three trial, conducted in partnership with the UK government’s Vaccines Taskforce.
Notably, this vaccine was also pitted against variants of the... Read More »
The results of the phase three ENSEMBLE clinical trial have shown that Johnson & Johnson’s single-shot Janssen COVID-19 vaccine candidate is 66 percent effective overall at preventing moderate to severe COVID-19 cases 28 days after vaccination.
The study also showed that the vaccine... Read More »
A new agreement between Sanofi and BioNTech grants the latter access to Sanofi’s infrastructure to aid manufacturing of the COVID-19 vaccine BioNTech has co-developed with Pfizer, granting them the ability to make more than 125 million doses for Europe from summer on.
“Although vaccination... Read More »
In new data released by Eli Lilly and Company, a cocktail of neutralizing antibodies bamlanivimab and etesevimab reduced COVID-19 related hospitalizations and deaths by 70 percent among more than 1,000 high-risk patients.
According to the report, which was based on the BLAZE-1 phase three... Read More »
According to a new study by the International Chamber of Commerce Research Foundation, the global economy stands to lose as much as $9.2 trillion if governments fail to ensure developing economy access to COVID-19 vaccines.
The study demonstrates the economic case to invest in the Access to... Read More »
The development and deployment of an effective vaccine for COVID-19 could be the turning point in the fight against the deadly pandemic, and companies involved in the process must make specific business and public health considerations simultaneously to help ensure a successful outcome, experts... Read More »
COVAX announced last week that a new purchase agreement with Pfizer-BioNTech will secure up to 40 million doses of COVID-19 vaccine for rollout, offering the potential to deliver at least 2 billion doses of vaccines, equitably, by year’s end.
“Today marks another milestone for COVAX:... Read More »
In an attempt to address U.S. global health security staffing and to provide a permanent designated official for coordinating interagency health response, 57 House members supported the reintroduction of the Global Health Security Act this week.
Led by U.S. Reps. Gerry Connolly (D-VA), president... Read More »
In a letter to President Joe Biden this week, U.S. Sens. Tammy Baldwin (D-WI) and Chris Murphy (D-CT) led 24 other senators in supporting full use of the Defense Production Act (DPA) to ramp up the production and stockpiling of medical, testing and protective equipment for use in the COVID-19... Read More »
The U.S. Department of Health and Human Services (HHS) will award nearly $20 million in funds from the Coronavirus Aid, Relief, and Economic Security Act (CARES) Act to increase data sharing between health information exchanges and immunization information systems.
“These CARES Act funds will... Read More »
The World Health Organization (WHO) hosted a virtual forum last week to identify knowledge gaps and set research priorities for vaccines against COVID-19.
At the forum – attended by more than 2,800 scientists from 130 countries – the participants discussed the safety and efficacy of existing... Read More »
An indictment was unsealed in Central Islip, N.Y., last week, charging 14 leaders in MS-13 who are known as the Ranfla Nacional, which operated as the organization’s board of directors, directing MS-13’s criminal activity for almost two decades.
The indictment charges the defendants with... Read More »
